Dermata Therapeutics, Inc.
DRMA
$5.50
-$0.33-5.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.48M | 9.72M | 3.16M | 6.14M | 4.95M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 151.60K | 283.70K | 359.70K | 525.60K | 145.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 8.00K | 2.00K | 12.60K | 18.00K | 144.30K |
| Total Current Assets | 6.64M | 10.01M | 3.53M | 6.69M | 5.24M |
|
|
|||||
| Total Current Assets | 6.64M | 10.01M | 3.53M | 6.69M | 5.24M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 6.64M | 10.01M | 3.53M | 6.69M | 5.24M |
|
|
|||||
| Total Accounts Payable | 413.70K | 1.40M | 808.00K | 863.60K | 1.33M |
| Total Accrued Expenses | 612.60K | 1.31M | 1.16M | 1.08M | 591.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.03M | 2.70M | 1.97M | 1.95M | 1.92M |
|
|
|||||
| Total Current Liabilities | 1.03M | 2.70M | 1.97M | 1.95M | 1.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.03M | 2.70M | 1.97M | 1.95M | 1.92M |
|
|
|||||
| Common Stock & APIC | 75.29M | 75.28M | 67.24M | 67.27M | 62.67M |
| Retained Earnings | -69.68M | -67.98M | -65.68M | -62.52M | -59.35M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 5.61M | 7.30M | 1.56M | 4.74M | 3.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 5.61M | 7.30M | 1.56M | 4.74M | 3.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 5.61M | 7.30M | 1.56M | 4.74M | 3.32M |
|
|
|||||